ADVERTISEMENT
US FDA approves expanded use of J&J's cancer cell therapyFDA allowed the expanded use of Johnson and Johnson Legend Biotech's Carvykti cell therapy as an earlier treatment for patients with a type of blood cancer.
Reuters
Last Updated IST
<div class="paragraphs"><p>The Johnson &amp; Johnson logo.</p></div>

The Johnson & Johnson logo.

Credit: Reuters Photo

The US Food and Drug Administration on Friday allowed the expanded use of Johnson and Johnson Legend Biotech's Carvykti cell therapy as an earlier treatment for patients with a type of blood cancer.

ADVERTISEMENT
ADVERTISEMENT
(Published 06 April 2024, 10:23 IST)